Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


27.03.2017

5 Anticancer Res
3 Biochem Biophys Res Commun
1 Eur Radiol
1 Gut
7 Hepatology
3 J Gastroenterol Hepatol
4 J Hepatol
2 Oncogene
1 PLoS Genet


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. DE PASQUALE MD, de Ville de Goyet J, Monti L, Grimaldi C, et al
    Bevacizumab Combined with Chemotherapy in Children Affected by Hepatocellular Carcinoma: a Single-center Experience.
    Anticancer Res. 2017;37:1489-1493.
    PubMed     Text format     Abstract available

  2. ITOH S, Uchiyama H, Ikeda Y, Morita K, et al
    Post-hepatectomy Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma: Risk Factor Analysis to Overcome this Problematic Complication.
    Anticancer Res. 2017;37:1381-1385.
    PubMed     Text format     Abstract available

  3. MARQUES LA, Semprebon SC, Sartori D, DE Fatima A, et al
    Comparison of the Effects of Monastrol and Oxomonastrol on Human Hepatoma Cell Line HepG2/C3A.
    Anticancer Res. 2017;37:1197-1204.
    PubMed     Text format     Abstract available

  4. YOSHIKAWA M, Morine Y, Ikemoto T, Imura S, et al
    Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition.
    Anticancer Res. 2017;37:1169-1175.
    PubMed     Text format     Abstract available

  5. KOMATSU H, Masuda T, Iguchi T, Nambara S, et al
    Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:1083-1090.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  6. MURAKI Y, Makita Y, Yamasaki M, Amano Y, et al
    Elevation of liver endoplasmic reticulum stress in a modified choline-deficient L-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
    Biochem Biophys Res Commun. 2017 Mar 17. pii: S0006-291X(17)30538.
    PubMed     Text format     Abstract available

  7. CHEN C, Song G, Xiang J, Zhang H, et al
    AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2017 Mar 18. pii: S0006-291X(17)30541.
    PubMed     Text format     Abstract available

  8. KRUGLOV E, Ananthanarayanan M, Sousa P, Weerachayaphorn J, et al
    Type 2 inositol trisphosphate receptor gene expression in hepatocytes is regulated by cyclic AMP.
    Biochem Biophys Res Commun. 2017 Mar 18. pii: S0006-291X(17)30553.
    PubMed     Text format     Abstract available


    Eur Radiol

  9. TALAKIC E, Schaffellner S, Kniepeiss D, Mueller H, et al
    CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
    Eur Radiol. 2017 Mar 20. doi: 10.1007/s00330-017-4788.
    PubMed     Text format     Abstract available


    Gut

  10. HAGSTROM H, Tynelius P, Rasmussen F
    High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men.
    Gut. 2017 Mar 20. pii: gutjnl-2016-313622. doi: 10.1136/gutjnl-2016-313622.
    PubMed     Text format     Abstract available


    Hepatology

  11. MOLLER S, Hove JD
    Assessment of systolic function in the evaluation of patients with cirrhosis.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29163.
    PubMed     Text format    

  12. DE MATTOS AZ, Miozzo SA, Tovo CV, de Mattos AA, et al
    Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29132.
    PubMed     Text format    

  13. BRAILLON A
    Screening for hepatocellular carcinoma: A drug safety issue.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29173.
    PubMed     Text format    

  14. NAHON P, Seror O, Durand-Zaleski I
    Reply to: <<Screening for Hepatocellular carcinoma: A drug safety issue>>.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29174.
    PubMed     Text format    

  15. SASAKI R, Devhare PB, Steele R, Ray R, et al
    Hepatitis C virus induced CCL5 secretion from macrophages activates hepatic stellate cells.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29170.
    PubMed     Text format     Abstract available

  16. CHANG FM, Wang YP, Lang HC, Tsai CF, et al
    Statins decrease the risk of decompensation in HBV- and HCV-related cirrhosis: A population-based study.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29172.
    PubMed     Text format     Abstract available

  17. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1081-1083.
    PubMed     Text format    


    J Gastroenterol Hepatol

  18. JIANG T, Du F, Qin N, Lu Q, et al
    Systematical analyses of variants in DNase I hypersensitive sites identified two novel hepatocellular carcinoma susceptibility loci among Chinese population.
    J Gastroenterol Hepatol. 2017 Mar 20. doi: 10.1111/jgh.13790.
    PubMed     Text format     Abstract available

  19. MIYATA T, Yamashita Y, Yamao T, Umezaki N, et al
    Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma.
    J Gastroenterol Hepatol. 2017;32:547.
    PubMed     Text format    

  20. HWANG HE, Tseng HS, Liu CA, Chiou YY, et al
    Hepatobiliary and Pancreatic: Obstructive jaundice after transarterial chemoembolization of hepatocellular carcinoma related to intraductal tumor necrotic fragment.
    J Gastroenterol Hepatol. 2017;32:546.
    PubMed     Text format    


    J Hepatol

  21. VILARINHO S, Erson-Omay Z, Mitchell-Richards K, Cha C, et al
    Exome Analysis of the Evolutionary Path of Hepatocellular Adenoma-Carcinoma Transition, Vascular Invasion and Brain Dissemination.
    J Hepatol. 2017 Mar 17. pii: S0168-8278(17)30143.
    PubMed     Text format     Abstract available

  22. HUANG A, Zhao X, Yang XR, Li FQ, et al
    Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma.
    J Hepatol. 2017 Mar 17. pii: S0168-8278(17)30139.
    PubMed     Text format     Abstract available

  23. PATOURAUX S, Rousseau D, Bonnafous S, Lebeaupin C, et al
    CD44 is a key player in non-alcoholic steatohepatitis.
    J Hepatol. 2017 Mar 16. pii: S0168-8278(17)30137.
    PubMed     Text format     Abstract available

  24. URBAN TJ, Nicoletti P, Chalasani N, Serrano J, et al
    Minocycline Hepatotoxicity: Clinical characterization and identification of HLA-B * 35:02 as a risk factor.
    J Hepatol. 2017 Mar 17. pii: S0168-8278(17)30144.
    PubMed     Text format     Abstract available


    Oncogene

  25. HU X, Zhao Y, Wei L, Zhu B, et al
    CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  26. ZHOU M, Mok MT, Sun H, Chan AW, et al
    The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS Genet

  27. SVEEN A, Loes IM, Alagaratnam S, Nilsen G, et al
    Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.
    PLoS Genet. 2016;12:e1006225.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: